Hosseini-Maaf Bahram, Hellberg Asa, Chester M Alan, Olsson Martin L
Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University and Blood Center, Lund University Hospital, Lund, Sweden.
Transfusion. 2007 Nov;47(11):2110-25. doi: 10.1111/j.1537-2995.2007.01436.x.
ABO genotyping is complicated by the remarkable diversity at the ABO locus. Recombination or gene conversion between common alleles may lead to hybrids resulting in unexpected ABO phenotypes. Furthermore, numerous mutations associated with weak subgroups and nondeletional null alleles should be considered. All known ABO genotyping methods, however, risk incorrect phenotype predictions if any such alleles are present.
An extensive set of allele-specific primers was designed to accomplish hybrid-proof multiplex polymerase chain reaction (PCR) amplification of DNA fragments for detection of ABO alleles. Results were compared with serologic findings and ABO genotypes defined by previously published PCR-restriction fragment length polymorphism/PCR-allele-specific polymorphism (ASP) methods or DNA sequencing.
Phenotypically well-characterized samples from blood donors with common blood groups and rare-subgroup families were analyzed. In addition to the commonly encountered alleles (A1, A1(467C>T), A2, B, O1, O1v, and O2), the new method can detect hybrid alleles thanks to long-range amplification across intron 6. Four of 12 PCR-ASP procedures are used to screen for multiple infrequent subgroup and null alleles. This concept allows for a low-resolution typing format in which the presence of, for example, a weak subgroup or cis-AB/B(A) is indicated but not further defined. In an optional high-resolution step, more detailed genotype information is obtained.
A new genotyping approach has been developed and evaluated that can correctly identify ABO alleles including nondeletional null alleles, subgroups, and hybrids resulting from recombinational crossing-over events between exons 6 and 7. This approach is clinically applicable and decreases the risk for erroneous ABO phenotype prediction compared to previously published methods.
ABO基因分型因ABO基因座的显著多样性而变得复杂。常见等位基因之间的重组或基因转换可能导致杂合子,从而产生意外的ABO血型表型。此外,还应考虑与弱亚型和非缺失性无效等位基因相关的众多突变。然而,如果存在任何此类等位基因,所有已知的ABO基因分型方法都有错误预测表型的风险。
设计了一套广泛的等位基因特异性引物,以完成用于检测ABO等位基因的DNA片段的防杂合多重聚合酶链反应(PCR)扩增。将结果与血清学结果以及通过先前发表的PCR-限制性片段长度多态性/PCR-等位基因特异性多态性(ASP)方法或DNA测序定义的ABO基因型进行比较。
分析了来自具有常见血型的献血者和罕见亚型家族的表型特征明确的样本。除了常见的等位基因(A1、A1(467C>T)、A2、B、O1、O1v和O2)外,由于跨越内含子6的长距离扩增,新方法还可以检测杂合等位基因。12种PCR-ASP程序中的4种用于筛查多种罕见亚型和无效等位基因。这一概念允许采用低分辨率分型格式,其中例如表明存在弱亚型或顺式AB/B(A),但不做进一步定义。在可选的高分辨率步骤中,可以获得更详细的基因型信息。
已开发并评估了一种新的基因分型方法,该方法可以正确识别ABO等位基因,包括非缺失性无效等位基因、亚型以及外显子6和7之间重组交叉事件产生的杂合子。与先前发表的方法相比,这种方法在临床上适用,并降低了ABO表型预测错误的风险。